Your browser doesn't support javascript.
loading
T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases.
Bridgewood, Charlie; Wittmann, Miriam; Macleod, Tom; Watad, Abdulla; Newton, Darren; Bhan, Kanchan; Amital, Howard; Damiani, Giovanni; Giryes, Sami; Bragazzi, Nicola Luigi; McGonagle, Dennis.
Afiliação
  • Bridgewood C; Leeds Institute of Rheumatic and Musculoskeletal Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Wittmann M; Leeds Institute of Rheumatic and Musculoskeletal Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom; Leeds Biomedical Research Centre, National Institute for Health Research, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom; Department of Dermatology, University Medica
  • Macleod T; Leeds Institute of Rheumatic and Musculoskeletal Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Watad A; Leeds Institute of Rheumatic and Musculoskeletal Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom; Zabludowicz Center for Autoimmune Diseases, Department of Medicine B., Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israe
  • Newton D; Division of Haematology and Immunology, University of Leeds, Leeds, United Kingdom.
  • Bhan K; Department of Ophthalmology, St James's University Hospital, Leeds, United Kingdom.
  • Amital H; Zabludowicz Center for Autoimmune Diseases, Department of Medicine B., Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Damiani G; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy; Clinical Dermatology, Scientific Hospitalization and Treatment Institute (IRCCS), Milan, Italy; PhD Degree Program in Pharmacological Sciences, Department of Pharmaceutical and Pharmacological Sciences, Univer
  • Giryes S; Leeds Institute of Rheumatic and Musculoskeletal Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom; B. Shine Rheumatology Unit, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Bragazzi NL; Leeds Institute of Rheumatic and Musculoskeletal Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom; Laboratory for Industrial and Applied Mathematics (LIAM), Department of Mathematics and Statistics, Faculty of Science, York University, Toronto, Ontario, Canada.
  • McGonagle D; Leeds Institute of Rheumatic and Musculoskeletal Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom; Leeds Biomedical Research Centre, National Institute for Health Research, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom. Electronic address: d.g.mcgonagle@leeds.ac.u
J Invest Dermatol ; 142(10): 2660-2667, 2022 10.
Article em En | MEDLINE | ID: mdl-35395222
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Psoríase / Doenças Autoimunes / Espondiloartropatias / MicroRNAs / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Entesopatia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Psoríase / Doenças Autoimunes / Espondiloartropatias / MicroRNAs / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Entesopatia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article